Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group Study

被引:274
|
作者
Mulhern, RK
Kepner, JL
Thomas, PR
Armstrong, FD
Friedman, HS
Kun, LE
机构
[1] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
[2] Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN USA
[3] Univ Tennessee, Coll Med, Dept Radiat Oncol, Memphis, TN USA
[4] Univ Florida, Dept Stat, Pediat Oncol Grp, Stat Off, Gainesville, FL 32611 USA
[5] Univ Miami, Sch Med, Dept Pediat, Miami, FL USA
[6] Temple Univ, Ctr Canc, Philadelphia, PA 19122 USA
[7] Temple Univ, Dept Radiat Oncol, Philadelphia, PA 19122 USA
[8] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
关键词
D O I
10.1200/JCO.1998.16.5.1723
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of this study was to ten the hypothesis that survivors of medulloblastoma who were younger at diagnosis and those who received standard-dose cranial irradiation (SRT) of 36 Gy would have a lower performance on standardized tests of cognitive function and achievement than children who were older and those treated with reduced-dose cranial irradiation (RRT) of 23.4 Gy. Patients and Methods: Eligible patients had been treated on Pediatric Oncology Group (POG) study 8631 for law-risk medulloblastoma that randomized patients to receive RRT or SRT after surgical resection. Those who were alive and free of progressive disease 6.1 to 9.9 years from completion of treatment were eligible for this study. Of the 35 eligible patients, 22 patients (13 SRT, nine RRT) participated in a battery of tests that included intellectual and academic development as well as ratings of health-related quality of life. Results: Patients were stratified by treatment group (SRT v RRT) and into younger (Y) and older (O) groups by the median age at diagnosis (8.85 years), which resulted in four groups that we hypothesized would show neuropsychologic test scores in the following order: Y/SRT less than Y/RRT less than O/SRT less than O/RRT. Evidence to support the hypothesized ordering of groups in terms of neuropsychologic toxicity wets obtained with regard to Performance Intelligence Quotient (IQ), Full Scale IQ, Attention, Reading, and Arithmetic. Conclusion: Children heated for medulloblastoma experienced less severe neuropsychologic toxicity when heated with 23.4 Gy instead of 36 Gy cranial irradiation. Older children experienced less toxicity than children who were younger at the time of irradiation. (C) 1998 by American Society of Clinical Oncology.
引用
收藏
页码:1723 / 1728
页数:6
相关论文
共 50 条
  • [1] Molecular characterization of long-term survivors of metastatic medulloblastoma treated with reduced-dose craniospinal irradiation
    Tomoya Irikura
    Kohei Fukuoka
    Atsuko Nakazawa
    Koichi Ichimura
    Jun Kurihara
    Katsuyoshi Koh
    Child's Nervous System, 2023, 39 : 2505 - 2507
  • [2] Molecular characterization of long-term survivors of metastatic medulloblastoma treated with reduced-dose craniospinal irradiation
    Irikura, Tomoya
    Fukuoka, Kohei
    Nakazawa, Atsuko
    Ichimura, Koichi
    Kurihara, Jun
    Koh, Katsuyoshi
    CHILDS NERVOUS SYSTEM, 2023, 39 (09) : 2505 - 2507
  • [3] Postoperative sandwich chemotherapy and reduced-dose craniospinal radiotherapy for pediatric medulloblastoma
    Ichikawa, T.
    Kambara, H.
    Chayama, K.
    Miyamura, T.
    Tamiya, T.
    Date, I.
    NEURO-ONCOLOGY, 2007, 9 (02) : 194 - 194
  • [4] Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients
    Massimino, Maura
    Sunyach, Marie Pierre
    Barretta, Francesco
    Gandola, Lorenza
    Garegnani, Anna
    Pecori, Emilia
    Spreafico, Filippo
    Bonneville-Levard, Alice
    Meyronet, David
    Mottolese, Carmine
    Boschetti, Luna
    Biassoni, Veronica
    Schiavello, Elisabetta
    Giussani, Carlo
    Carrabba, Giorgio
    Diletto, Barbara
    Pallotti, Federica
    Stefini, Roberto
    Ferrari, Andrea
    Terenziani, Monica
    Casanova, Michela
    Luksch, Roberto
    Meazza, Cristina
    Podda, Marta
    Chiaravalli, Stefano
    Puma, Nadia
    Bergamaschi, Luca
    Morosi, Carlo
    Calareso, Giuseppina
    Giangaspero, Felice
    Antonelli, Manila
    Buttarelli, Francesca Romana
    Frappaz, Didier
    JOURNAL OF NEURO-ONCOLOGY, 2020, 148 (03) : 619 - 628
  • [5] Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients
    Maura Massimino
    Marie Pierre Sunyach
    Francesco Barretta
    Lorenza Gandola
    Anna Garegnani
    Emilia Pecori
    Filippo Spreafico
    Alice Bonneville-Levard
    David Meyronet
    Carmine Mottolese
    Luna Boschetti
    Veronica Biassoni
    Elisabetta Schiavello
    Carlo Giussani
    Giorgio Carrabba
    Barbara Diletto
    Federica Pallotti
    Roberto Stefini
    Andrea Ferrari
    Monica Terenziani
    Michela Casanova
    Roberto Luksch
    Cristina Meazza
    Marta Podda
    Stefano Chiaravalli
    Nadia Puma
    Luca Bergamaschi
    Carlo Morosi
    Giuseppina Calareso
    Felice Giangaspero
    Manila Antonelli
    Francesca Romana Buttarelli
    Didier Frappaz
    Journal of Neuro-Oncology, 2020, 148 : 619 - 628
  • [6] Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: A French Society of Pediatric Oncology study
    Oyharcabal-Bourden, V
    Kalifa, C
    Gentet, JC
    Frappaz, D
    Edan, C
    Chastagner, P
    Sariban, E
    Pagnier, A
    Babin, A
    Pichon, F
    Neuenschwander, S
    Vinchon, M
    Bours, D
    Mosseri, V
    Le Gales, C
    Ruchoux, M
    Carrie, C
    Doz, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4726 - 4734
  • [7] Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study
    Fukuoka, Kohei
    Kurihara, Jun
    Shofuda, Tomoko
    Kagawa, Naoki
    Yamasaki, Kai
    Ando, Ryo
    Ishida, Joji
    Kanamori, Masayuki
    Kawamura, Atsufumi
    Park, Young-Soo
    Kiyotani, Chikako
    Akai, Takuya
    Keino, Dai
    Miyairi, Yosuke
    Sasaki, Atsushi
    Hirato, Junko
    Inoue, Takeshi
    Nakazawa, Atsuko
    Koh, Katsuyoshi
    Nishikawa, Ryo
    Date, Isao
    Nagane, Motoo
    Ichimura, Koichi
    Kanemura, Yonehiro
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2023, 11 (01)
  • [8] Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study
    Kohei Fukuoka
    Jun Kurihara
    Tomoko Shofuda
    Naoki Kagawa
    Kai Yamasaki
    Ryo Ando
    Joji Ishida
    Masayuki Kanamori
    Atsufumi Kawamura
    Young-Soo Park
    Chikako Kiyotani
    Takuya Akai
    Dai Keino
    Yosuke Miyairi
    Atsushi Sasaki
    Junko Hirato
    Takeshi Inoue
    Atsuko Nakazawa
    Katsuyoshi Koh
    Ryo Nishikawa
    Isao Date
    Motoo Nagane
    Koichi Ichimura
    Yonehiro Kanemura
    Acta Neuropathologica Communications, 11
  • [9] Ovarian Function in Survivors of Childhood Medulloblastoma: Impact of Reduced Dose Craniospinal Irradiation and High-Dose Chemotherapy With Autologous Stem Cell Rescue
    Balachandar, Sadana
    Dunkel, Ira J.
    Khakoo, Yasmin
    Wolden, Suzanne
    Allen, Jeffrey
    Sklar, Charles A.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 317 - 321
  • [10] Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium
    Okada, Keiko
    Soejima, Toshinori
    Sakamoto, Hiroaki
    Hirato, Junko
    Hara, Junichi
    PEDIATRIC BLOOD & CANCER, 2020, 67 (11)